TRVI
Trevi Therapeutics, Inc.Healthcare$11.94
▲ Bullish
Mkt Cap: $1.53B|Float: 103.9M|SI: 15.8%|DTC: 12.9
Data as of market close Apr 2, 2026
IV Rank
32
IV Pctl
22%
HV 20d
69.1%
52W Range
$5-$14
ATR(14)
$0.79
Exp. Move
±12.1%
P/C Ratio
0.44
Earnings
May 7
GEX Positive
DEX Long
Net Call Premium
IV Moderate
Max Pain Below
Exp. Move Wide
Low Put/Call
TRVI Key Options Data
- IV Rank
- 31.7%
- Total GEX
- $0.00B
- Total DEX
- $0.7M
- Max Pain
- $9.00
- Expected Move
- ±12.1%
- Put/Call OI
- 0.44
- Net Premium
- $0.3M
- Spot Price
- $11.94
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$1.45 | ±12.1% | $10.49 | $13.39 |
| 2026-07-17 | 106 | ±$4.90 | ±41.0% | $7.04 | $16.84 |
| 2027-01-15 | 288 | ±$6.20 | ±51.9% | $5.74 | $18.14 |
Explore TRVI options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.